Glycolysis Cancer Research Results

Glycolysis, Glycolysis: Click to Expand ⟱
Source:
Type:
Glycolysis is a metabolic pathway that converts glucose into pyruvate, producing a small amount of ATP (energy) in the process. It is a fundamental process for cellular energy production and occurs in the cytoplasm of cells. In normal cells, glycolysis is tightly regulated and is followed by aerobic respiration in the presence of oxygen, which allows for the efficient production of ATP.
In cancer cells, however, glycolysis is often upregulated, even in the presence of oxygen. This phenomenon is known as the Warburg Mutations in oncogenes (like MYC) and tumor suppressor genes (like TP53) can alter metabolic pathways, promoting glycolysis and other anabolic processes that support cell growth.effect.
Acidosis: The increased production of lactate from glycolysis can lead to an acidic microenvironment, which may promote tumor invasion and suppress immune responses.

Glycolysis is a hallmark of malignancy transformation in solid tumor, and LDH is the key enzyme involved in glycolysis.

Pathways:
-GLUTs, HK2, PFK, PK, PKM2, LDH, LDHA, PI3K/AKT/mTOR, AMPK, HIF-1a, c-MYC, p53, SIRT6, HSP90α, GAPDH, HBT, PPP, Lactate Metabolism, ALDO

Natural products targeting glycolytic signaling pathways https://pmc.ncbi.nlm.nih.gov/articles/PMC9631946/
Alkaloids:
-Berberine, Worenine, Sinomenine, NK007, Tetrandrine, N-methylhermeanthidine chloride, Dauricine, Oxymatrine, Matrine, Cryptolepine

Flavonoids: -Oroxyline A, Apigenin, Kaempferol, Quercetin, Wogonin, Baicalein, Chrysin, Genistein, Cardamonin, Phloretin, Morusin, Bavachinin, 4-O-methylalpinumisofavone, Glabridin, Icaritin, LicA, Naringin, IVT, Proanthocyanidin B2, Scutellarin, Hesperidin, Silibinin, Catechin, EGCG, EGC, Xanthohumol.

Non-flavonoid phenolic compounds:
Curcumin, Resveratrol, Gossypol, Tannic acid.

Terpenoids:
-Cantharidin, Dihydroartemisinin, Oleanolic acid, Jolkinolide B, Cynaropicrin, Ursolic Acid, Triptolie, Oridonin, Micheliolide, Betulinic Acid, Beta-escin, Limonin, Bruceine D, Prosapogenin A (PSA), Oleuropein, Dioscin.

Quinones:
-Thymoquinone, Lapachoi, Tan IIA, Emodine, Rhein, Shikonin, Hypericin

Others:
-Perillyl alcohol, HCA, Melatonin, Sulforaphane, Vitamin D3, Mycoepoxydiene, Methyl jasmonate, CK, Phsyciosporin, Gliotoxin, Graviola, Ginsenoside, Beta-Carotene.


Scientific Papers found: Click to Expand⟱
6857- FBZ,    Fenbendazole induces pyroptosis in breast cancer cells through HK2/caspase-3/GSDME signaling pathway
- vitro+vivo, BC, NA
tumCV↓, Pyro↑, cl‑Casp3↑, GSDME↑, IL1β↑, Glycolysis↓, HK2↓, TumVol↓, TumW↓, toxicity↓,
2494- FBZ,    Oral Fenbendazole for Cancer Therapy in Humans and Animals
- Review, Var, NA
Glycolysis↓, GlucoseCon↓, ROS↑, Apoptosis↑, BioAv↓, Synergy↑, toxicity↓, BioAv↑, BioAv↑, hepatoP↓, Synergy↑,
2313- Flav,    Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
- Review, Var, NA
Warburg↓, antiOx↑, angioG↓, Glycolysis↓, PKM2↓, PKM2:PKM1↓, β-catenin/ZEB1↓, cMyc↓, HK2↓, Akt↓, mTOR↓, GLUT1↓, Hif1a↓,
5206- Gallo,    Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells
- in-vitro, Var, NA
LDHA↓, Glycolysis↓, TumCP↓,
5205- Gallo,    Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
- in-vitro, Endo, ISH
LDH↓, TumCG↓, LDHA↓, Apoptosis↑, cl‑Casp3↑, Mcl-1↓, Bcl-2↓, TumCCA↑, ROS↑, mt-DNAdam↑, GlucoseCon↓, ATP↓, PDH↑, Pyruv↑, Glycolysis↓, TCA↑, cMyc↓, E-cadherin↑, Slug↓,
935- Gallo,    Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
LDH↓, ROS↑, TumCP↓, Glycolysis↓, ATP↓, ER-α36↓, Apoptosis?,
934- Gallo,    Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase
- Analysis, Var, NA
LDH↓, Glycolysis↓, Apoptosis↑,
7286- GGB,    Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer
- in-vitro, Lung, A549 - in-vitro, Lung, PC9
Hif1a↓, Glycolysis↓, OXPHOS↑, ROS↑, Apoptosis↑, toxicity↓, PDKs↓, HK2↓, LDHA↓, PFKFB2↓, PKM2↓, Synergy↑,
7282- Gins,    Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex
- in-vitro, Cerv, NA
compI↓, compIII↓, ETC↓, ROS↑, Apoptosis↑, tumCV↓, selectivity↑, MMP↓, ATP↓, OXPHOS↓, ECAR↓, Glycolysis↓,
7297- GlaB,    H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma
- vitro+vivo, GBM, NA
TumCG↓, Glycolysis↑, lactateProd↑, Warburg↑, eff↑, Gli1↓,
7321- Gos,    The potential roles of gossypol as anticancer agent: advances and future directions
- Review, Var, NA
other↝, BioAv↑, Bcl-2↓, Casp3↑, Casp9↑, MOMP↑, ROS↑, ATP↓, mtDam↑, Apoptosis↑, hTERT/TERT↓, Akt↓, TumAuto↑, LC3‑Ⅱ/LC3‑Ⅰ↑, NRF2↓, ARE↓, ICAM-1↓, CX43/GJA1↓, NF-kB↓, TLR4↓, IL6↓, Inflam↓, CUL5↝, CUL1↝, NOXA↑, TumCI↓, TumCMig↓, TumCA↓, FAK↓, MDM2↓, VEGF↓, angioG↓, HLA-I/II↑, Imm↑, Dose↝, Glycolysis↓, OXPHOS↓,
2512- H2,    Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch
- in-vivo, Asthma, NA
*selectivity↑, *lactateProd↓, *ATP↑, *HK2↓, *PFK↓, *Hif1a↓, *PGC-1α↑, *Glycolysis↓, *OXPHOS↑, *Dose↝, *antiAll↑,
7503- H2S,    Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells
- Review, Var, NA
DNArepair↑, CBS↑, 3MST/MPST↑, ETC↑, ATP↑, Glycolysis↑, ACLY↑,
2400- HCAs,    The Mixture of Ferulic Acid and P-Coumaric Acid Suppresses Colorectal Cancer through lncRNA 495810/PKM2 Mediated Aerobic Glycolysis
- in-vitro, CRC, NA - in-vivo, CRC, NA
PKM2↓, Glycolysis↓, TumCG↓,
7468- HNK,    Honokiol and Its Emerging Role in Breast Cancer Therapy
- Review, BC, NA
*ROS↓, *Inflam↓, CSCs↓, ChemoSen↑, BioAv↑, ROS↑, MMP↓, mtDam↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓, BAX↑, p‑STAT3↓, AMPK↑, miR-34a↑, EMT↓, HH↓, Shh↓, Gli1↓, PTCH1↓, NF-kB↓, TNF-α↓, IL6↓, Glycolysis↓, GlucoseCon↓, BioAv↓, BioAv↓, Half-Life↝,
2887- HNK,    Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming
- in-vitro, AD, BV2
*Glycolysis↑, *ATP↑, *ROS↓, *MMP↑, *OXPHOS↑, *PPARα↑, *PGC-1α↑,
960- HNK,    Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, MDA-MB-231
OCR↑, ECAR↓, GlucoseCon↓, lactateProd↓, ATP↓, Glycolysis↓, Hif1a↓, GLUT1↓, HK2↓, PDK1 / PDPK1↓, Apoptosis↑, LDHA↓,
2071- HNK,    Identification of senescence rejuvenation mechanism of Magnolia officinalis extract including honokiol as a core ingredient
- Review, Nor, HaCaT
*ROS↓, *antiOx↑, *AntiAge↑, *MMP↑, *ECAR↓, *Glycolysis↓, *PAR-2↓, *CXCL12↑, *BMAL1↑, *mt-ROS↓, *OXPHOS↓,
7630- Ins,    Modulation of both Insulin Resistance and Cancer Growth by Inositol
- Review, Var, NA - Review, Diabetic, NA
*IRes↓, *AntiDiabetic↑, *glucose↝, AntiCan↑, PI3K↓, Akt↓, Glycolysis↓, STK11/LKB1↑, *FASN↓, *LDL↓, *FFA/NEFA↓, *ROS↓, ROS↑, IGF-1↓,
7758- ISL,    Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications
- Review, Ovarian, NA
JAK↓, STAT↓, toxicity↓, *antiOx↑, *ROS↓, *NRF2↑, *ARE↑, *HO-1↑, *NQO1↑, *Inflam↓, *NF-kB↓, *MAPK↓, *SOD↑, *Catalase↑, *GPx↑, *AntiViral↑, *NADPH↑, ROS↓, p38↓, mTOR↓, STAT3↓, cycD1/CCND1↓, survivin↓, p38↑, MAPK↑, mtDam↑, ER Stress↑, ROS↑, Apoptosis↑, GLUT4↓, ATP↓, Glycolysis↓, eff↑,
7760- ISL,    Pharmacological Potentials and Delivery Strategies of Isoliquiritigenin: Challenges and Advances in Enhancing Bioavailability
- Review, Nor, NA
*BioAv↓, GlucoseCon↓, LDH↓, PDK1 / PDPK1↓, Glycolysis↓, mt-OXPHOS↓, Bax:Bcl2↓, cl‑Casp3↑, cl‑Casp9↑, Apoptosis↑, Hif1a↓, ROS↑, *AntiDiabetic↑, *cardioP↑, *RenoP↑, *ROS↓, *NF-kB↓, *NLRP3↓, *Pyro↓, *antiPs↑, *IL6↓, *IL8↓, CompStab↑, BioAv↑, BioAv↑,
7761- ISL,    Targeting digestive system cancers with isoliquiritigenin: a comprehensive review of antitumor mechanisms
- Review, Var, NA
Apoptosis↑, TumAuto↑, TumCCA↑, ROS↑, JNK↑, p38↑, STAT3↑, NF-kB↓, IκB↑, Bcl-2↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, P21↑, p27/CDKN1B↑, CycB/CCNB1↑, CDK1↓, CDK2↓, GRP78/BiP↓, PI3K↓, Akt↓, mTOR↓, eff↑, GLUT4↓, lactateProd↓, OXPHOS↓, Glycolysis↓, BioAv↑, ENO1↓, ALDOA↓, LDHA↓, MCT4↓, RadioS↑, Ferroptosis↑, i-Iron↑, BioAv↑, Half-Life↓,
9244- ISO, IH,    Isorhamnetin inhibits bladder cancer progression by mediating glycolysis through targeting the SRC/PI3K/Akt axis
- in-vitro, Bladder, 5637
TumCP↓, TumCMig↓, TumCI↓, TumCA↓, Glycolysis↓, TumCCA↑, Apoptosis↑, p‑Src↓, PI3K↓, Akt↓, mTOR↓, HK2↓, GLUT1↓, PFKFB3↓, ECAR↓, OCR↓, GlucoseCon↓, lactateProd↓,
7793- ISQ,    Apoptosis triggered by isoquercitrin in bladder cancer cells by activating the AMPK-activated protein kinase pathway
- in-vitro, Bladder, T24/HTB-9
tumCV↓, ROS↑, AMPK↑, Glycolysis↓, p‑PI3K↓, p‑Akt↓, Casp↑, mTOR↓, ACC↓, FASN↓,
9177- ITCs,  SFN,    Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
- Review, Var, NA
CSCs↓, GutMicro↑, Bacteria↓, TumCCA↑, Apoptosis↑, TumAuto↑, angioG↓, TumCI↓, TumMeta↓, NRF2↑, Glycolysis↓, Wnt↓, β-catenin/ZEB1↓, HH↓, NOTCH↓, NK cell↑, EMT↓, angioG↓, BioAv↓, BioAv↑, AntiBio↑, Bacteria↓, HK2↓, PDH↓, OXPHOS↓, AKT1↓, ACC1↓, FASN↓, ACC-α↓, ACLY↓, SREBP1/SREBF1↓, OCT4↓, Nanog↓, YAP/TEAD↓, miR-21↓, miR-29b↓, ALDH1A1↓, miR-140↑, CD44↓, BMI1↓, miR-200c↑, TumCG↓, TumCI↓, TumCMig↓, E-cadherin↑, N-cadherin↓, Vim↓, α-SMA↓, Slug↓, Snail↓, Twist↓, DNAdam⇅, BioAv↓, ChemoSen↑,
2178- itraC,    Itraconazole inhibits tumor growth via CEBPB-mediated glycolysis in colorectal cancer
- in-vivo, CRC, HCT116
TumCG↓, Glycolysis↓, CEBPB?, ENO1↓, LDHA↓, PKM2↓, GAPDH↓, ECAR↓, OCR↓,
1070- IVM,    Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation
- vitro+vivo, GBM, NA
TumCG↓, LC3II↑, p62↓, ATP↓, Pyruv↓, GlucoseCon↑, HK2↓, PFK1↓, GLUT4↓, Glycolysis↓, JAK2↓, p‑STAT3↓, p‑STAT5↓,
8087- KAE,    Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways
- Review, Var, NA
TumCCA↓, ROS↝, Apoptosis↑, TumCP↑, TumMeta↓, angioG↓, PI3K↓, EMT↓, Snail↓, E-cadherin↓, N-cadherin↓, MMP2↓, Casp9↑, Casp7↑, PARP↑, Apoptosis↑, *ROS↓, Hif1a↓, p‑Akt↓, P53↑, cMyc↓, Glycolysis↓, PKM2↓, miR-339-5p↝, BioAv↓,
8089- KAE,    Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1
- in-vitro, Melanoma, A375 - in-vitro, Melanoma, B16-F10
TumCMig↓, TumCI↓, TumMeta↓, ECAR↓, GlucoseCon↓, ATP↓, Pyruv↓, lactateProd↓, HK2↓, VDAC1↓, Akt↓, GSK‐3β↝, Glycolysis↓,
8092- KAE,    Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells
- in-vitro, Colon, HCT116 - in-vitro, Colon, DLD1
TumCP↓, TumCCA↑, Apoptosis↑, GlucoseCon↓, lactateProd↓, ATP↓, miR-339-5p↑, Glycolysis↓, PKM2↓, PKM1↑,
8101- KAE,    Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway
- vitro+vivo, ESCC, KYSE150 - vitro+vivo, ESCC, Eca109
TumCCA↑, TumCP↓, Glycolysis↓, HK2↓, GlucoseCon↓, lactateProd↓, EGFR↓, TumCG↓, P21↑, Dose↝, Ki-67↓,
8071- KAE,    Cellular reprogramming and signaling control by kaempferol in colorectal cancer
- Review, CRC, NA
*toxicity↓, Risk↓, MMPs↓, VEGF↓, VEGFR1↓, Wnt↓, β-catenin/ZEB1↑, PI3K↓, Akt↓, mTOR↓, ChemoSen↑, *BioAv↓, TumCCA↑, Apoptosis↑, Hif1a↓, ROS↑, TumCMig↓, TumMeta↓, PKM2↓, Glycolysis↓, DNAdam↑, HO-1↑, Ferroptosis↑, eff↑, Dose↝, BioAv↑,
8077- KAE,    Kaempferol exerts anti-colorectal cancer effects through its multi-target mediated glucose metabolism remodeling
- in-vitro, CRC, NA
AntiTum↑, Glycolysis↓, PPP↓, OXPHOS↑, ROS↑, MMP↓, Apoptosis↑, TKT↓, ALDOA↓, TumCP↓,
8081- KAE,    The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer
- Review, BC, NA
*antiOx↓, *Inflam↓, *neuroP↓, *AntiCan↑, DNAdam↓, Casp3↑, Casp9↑, p‑AMT/GCST/T-protein↑, ROS↑, NRF2↑, Apoptosis↑, cl‑PARP↓, BAX↑, Bcl-2↓, TumCCA↓, angioG↓, MMP3↓, MMP9↓, ChemoSen↑, BioAv↓, Glycolysis↓, cl‑PARP↑, Ca+2↑, MMP↓, ER Stress↑, GRP78/BiP↑, CHOP/DDIT3↑, ATF6↑, angioG↓, VEGF↓, Hif1a↓, chemoP↑, *ROS↓, NRF2↑, BioAv↑,
8082- KAE,  ART/DHA,  SK,    Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review
- Review, Cerv, NA
Glycolysis↓,
8055- KAE,    Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review
- Review, Var, NA
antiNeop↑, *toxicity↓, TumCCA↑, ROS↑, ER Stress↑, TumAuto↑, Pyro↑, Ferroptosis↑, angioG↓, Imm↝, Synergy↑, ChemoSen↑, MPT↑, MMP↓, mtDam↑, Cyt‑c↑, Bax:Bcl2↑, Fas↑, DR4↑, DR5↑, JNK↑, ERK↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, Ca+2↑, PI3K↓, Akt↓, mTOR↓, AMPK↑, *Ferroptosis↓, *antiOx↑, *NRF2↑, *GPx4↑, *ROS↓, *MDA↓, *i-Iron↓, *xCT/SLC7A11↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, EMT↓, STAT3↓, M2 MC↓, MCP1/CCL2↓, MMP9↓, MMP2↓, TIMP2↓, ChemoSen↑, PKM2↑, Glycolysis↓, CSCs↓, SOX4↓, OCT4↓, CD44↓, Nanog↓, MDR1↓, *GutMicro↑,
2390- KAE,    Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
- in-vitro, CRC, HCT8
eff↑, GlucoseCon↓, lactateProd↓, PKM2↓, Glycolysis↓, glucose↑,
2351- lamb,    Anti-Warburg effect via generation of ROS and inhibition of PKM2/β-catenin mediates apoptosis of lambertianic acid in prostate cancer cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
proCasp3↓, proPARP↓, LDHA↓, Glycolysis↓, HK2↓, PKM2↓, lactateProd↓, p‑STAT3↓, cycD1/CCND1↓, cMyc↓, β-catenin/ZEB1↓, p‑GSK‐3β↓, ROS↑, eff↓, Warburg↓,
8162- LapC,    Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
- in-vitro, Melanoma, MEL526 - in-vitro, Melanoma, MEL697 - in-vitro, Melanoma, MEL103
Glycolysis↓, OCR↑, PKM2↓, ATP↓, TumCP↓, Apoptosis↑, OXPHOS↑, Dose↝,
8237- LCA,    Role of Licochalcone A in Potential Pharmacological Therapy: A Review
- Review, Var, NA
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
8235- LCA,    Anticancer effects of licochalcones: A review of the mechanisms
- Review, Var, NA
mt-Apoptosis↑, TumAuto↑, TumCMig↓, LC3‑Ⅱ/LC3‑Ⅰ↑, ATG5↑, ATG7↑, p62↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, ATG3↑, Beclin-1/ATG6↑, ATG16L1↑, PERK↑, ATF4↑, ATP↓, Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, Bcl-xL↓, Bcl-2↓, BAD↑, BAX↑, Casp3↑, survivin↓, EGFR↓, ERK↓, Akt↓, mtDam↑, MMP↓, Cyt‑c↑, Casp↑, MDM2↓, CycB/CCNB1↓, CDC2↓, CDC25↓, TumCCA↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, Sp1/3/4↓, MMP-10↓, MMP3↓, TumCI↓, Imm↑, PD-L1↓, ROS↑, 4E-BP1↓, eIF2α↓, PI3K↓, mTOR↓, p‑cMET↑, Ca+2↑, RUBCN↓, ATG13↑, TSC1↑, TSC2↑, PRAS40↑, PP2A↑, ULK1/ATG1↑, THEM4/CTMP↑, DR5↑, Fas↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, PKCδ↓, P70S6K↓, VEGF↓, angioG↓, HK2↓, Glycolysis↓, TrxR1↓, APAF1↑, cl‑PARP↑, Bax:Bcl2↑, ABCG2↓, BioEnh↑,
8281- LE,    A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells
- in-vitro, Liver, NA
Apoptosis↑, TumCCA↑, Let-7↑, miR-34b-5p↑, miR-122-5p↑, miR-126↑, miR-195↑, miR-199↑, miR-206↑, miR-326-5p↑, Hif1a↓, PI3K↓, cMyc↓, AMPK↑, P53↑, Glycolysis↓, HK2↓, LDHA↓, PKM2↓, PPP↓, G6PD↓, GlutaM↓, GLS↓, miR-21↑, miR-221↑, miR-222↑,
2453- LE,    The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
- Review, Var, NA
HK2↓, PI3K↓, Akt↓, TumCP↓, Glycolysis↓,
986- LT,  doxoR,    Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells
- in-vitro, BC, 4T1 - in-vitro, BC, MCF7
SOD↓, Catalase↓, Glycolysis↓,
2929- LT,    Loss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: A window of opportunity for ovarian cancer chemoprevention
- in-vitro, Ovarian, NA
HK2↓, Myc↓, Glycolysis↓,
3276- Lyco,    Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
- in-vivo, HCC, NA
G6PD↓, PCNA↓, cycD1/CCND1↓, P21↑, Hif1a↓, Glycolysis↓,
2545- M-Blu,    Reversing the Warburg Effect as a Treatment for Glioblastoma
- in-vitro, GBM, U87MG - NA, AD, NA - in-vitro, GBM, A172 - in-vitro, GBM, T98G
Warburg↓, OCR↑, lactateProd↓, TumCP↓, TumCCA↑, AMPK↑, ACC↓, Cyc↓, neuroP↑, Cyt‑c↝, Glycolysis↓, ECAR↓, TumCG↓, other↓,
2542- M-Blu,    In Vitro Methylene Blue and Carboplatin Combination Triggers Ovarian Cancer Cells Death
- in-vitro, Ovarian, OV1369 - in-vitro, Ovarian, OV1946 - in-vitro, Nor, ARPE-19
BioAv↝, TumCP↓, GlutaM↓, Warburg↓, OCR↑, Glycolysis↓, ATP↓, BioAv↝, ROS↑,
2541- M-Blu,    Spectroscopic Study of Methylene Blue Interaction with Coenzymes and its Effect on Tumor Metabolism
- in-vivo, Var, NA
TumCG↓, Glycolysis↓, OXPHOS↑, ROS↑, OCR↑, GlucoseCon↑, lactateProd↓,
2540- M-Blu,    Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots
- Review, Var, NA - Review, AD, NA
*OCR↑, *Glycolysis↓, *GlucoseCon↑, neuroP↑, Warburg↓, mt-OXPHOS↑, TumCCA↑, TumCP↓, ROS⇅, *cognitive↑, *mTOR↓, *mt-antiOx↑, *memory↑, *BBB↑, *eff↝, *ECAR↓, eff↑, lactateProd↓, NADPH↓, OXPHOS↑, AMPK↑, selectivity↑,

Showing Research Papers: 151 to 200 of 327
Prev Page 4 of 7 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 327

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 1,   ARE↓, 1,   Catalase↓, 3,   Catalase↑, 1,   Fenton↑, 1,   GPx↓, 2,   GPx↑, 3,   GPx4↓, 5,   GSH↓, 23,   GSH/GSSG↓, 1,   GSTs↑, 1,   H2O2↓, 1,   H2O2↑, 7,   mt-H2O2↑, 1,   HO-1↓, 2,   HO-1↑, 8,   HO-2↓, 1,   Iron↑, 4,   i-Iron↑, 1,   lipid-P↓, 1,   lipid-P↑, 5,   lipidDe↓, 1,   MDA↑, 3,   i-MDA↑, 1,   NADH↓, 2,   NADPH/NADP+↓, 1,   NQO1↑, 1,   Nrf1↓, 1,   NRF2↓, 5,   NRF2↑, 12,   p‑NRF2↓, 1,   Prx4↑, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 1,   ROS↓, 11,   ROS↑, 123,   ROS⇅, 2,   ROS↝, 2,   i-ROS↑, 1,   mt-ROS↓, 1,   mt-ROS↑, 6,   RPM↑, 2,   SOD↓, 4,   SOD↑, 2,   SOD1↑, 1,   SOD2↓, 1,   SOD2↑, 3,   TAC↓, 1,   Thiols↓, 1,   TKT↓, 1,   TKT↝, 1,   TrxR↓, 5,   TrxR1↓, 3,   xCT/SLC7A11↓, 3,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 2,   FTH1↓, 1,   NCOA4↑, 1,   Zn2+↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   CDC2↓, 1,   CDC2↑, 1,   CDC25↓, 1,   compI↓, 4,   compIII↓, 1,   ETC↓, 3,   ETC↑, 1,   Insulin↓, 1,   KIF2C↓, 1,   mitResp↓, 11,   mitResp↑, 4,   mtDam↑, 14,   OCR↓, 15,   OCR↑, 10,   OXPHOS↓, 18,   OXPHOS↑, 20,   OXPHOS⇅, 1,   OXPHOS↝, 1,   mt-OXPHOS↓, 5,   mt-OXPHOS↑, 2,   PDH↓, 9,   PDH↑, 9,   p‑PDH↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 1,   SDH↓, 2,   SIRT3↑, 3,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

3MST/MPST↑, 1,   5LO↓, 2,   ACC↓, 3,   ACC-α↓, 1,   ACC1↓, 2,   ACLY↓, 5,   ACLY↑, 1,   ACSL1↓, 1,   adiP↑, 1,   Alanine↓, 1,   ALAT↓, 2,   ALDOA↓, 4,   ALDOAiso2↓, 1,   AminoA↓, 1,   AMPK↑, 23,   p‑AMPK↑, 1,   p‑AMT/GCST/T-protein↑, 1,   ATP↓, 63,   ATP↑, 4,   i-ATP↓, 1,   i-ATP↑, 1,   mt-ATP↓, 1,   ATP:AMP↓, 1,   CAIX/CA9↓, 3,   CBS↑, 1,   citrate↓, 2,   i-citrate↑, 1,   CPT1A↓, 3,   ECAR↓, 26,   ECAR↑, 1,   ECAR↝, 1,   ECAR∅, 1,   ENO1↓, 6,   FAO↓, 3,   FASN↓, 9,   FASN↑, 2,   FBP1↑, 1,   FBPase↑, 3,   G6PD↓, 7,   GAPDH↓, 7,   GDH↓, 1,   GLO-I↓, 1,   GLS↓, 3,   glucoNG↓, 1,   glucoNG↑, 2,   glucose↓, 2,   glucose↑, 1,   GlucoseCon↓, 70,   GlucoseCon↑, 4,   glut↓, 1,   GlutaM↓, 3,   glyC↓, 1,   Glycine↓, 1,   Glycolysis↓, 298,   Glycolysis↑, 6,   Glycolysis↝, 2,   Glycolysis∅, 1,   GSK‐3β↓, 1,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 2,   HAGH/GLO2↓, 1,   HK1↓, 4,   HK2↓, 104,   HK2↑, 2,   HK2∅, 1,   HMG-CoA↓, 1,   IDH1↑, 2,   lact/pyru↓, 1,   lactateProd↓, 90,   lactateProd↑, 4,   e-lactateProd↓, 1,   LDHA↓, 58,   LDHA↑, 1,   LDHA∅, 1,   lipoGen↓, 1,   MCT4↓, 4,   NAD↓, 3,   NADPH↓, 8,   OAA↑, 1,   PDHA1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 28,   p‑PDK1 / PDPK1↓, 2,   PDK3↓, 1,   PDK3↑, 1,   PDKs↓, 6,   p‑PDKs↓, 1,   PFK↓, 14,   PFK1↓, 9,   PFK1↑, 1,   PFK2?, 1,   PFK2↓, 3,   PFKFB3↓, 2,   PFKP?, 1,   PFKP↓, 3,   PGK1↓, 3,   PGM1↓, 1,   PKM1↑, 2,   PKM2↓, 93,   PKM2↑, 1,   PKM2∅, 1,   p‑PKM2↓, 1,   PKM2:PKM1↓, 2,   PPP↓, 7,   PPP↑, 1,   PYGL↓, 1,   Pyruv↓, 6,   Pyruv↑, 1,   R5P↝, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 2,   SIRT2↑, 1,   SREBP1/SREBF1?, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 2,   TCA↓, 10,   TCA↑, 3,   Warburg↓, 35,   Warburg↑, 2,   β-oxidation↓, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 6,   APAF1↑, 2,   Apoptosis?, 3,   Apoptosis↑, 90,   mt-Apoptosis↑, 1,   ASK1↑, 1,   BAD↑, 3,   BAX↓, 2,   BAX↑, 22,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 7,   Bcl-2↓, 27,   Bcl-2↑, 1,   Bcl-xL↓, 6,   BIM↑, 3,   BNIP3↝, 1,   Casp↑, 10,   Casp12↑, 1,   Casp2↑, 2,   Casp3↓, 2,   Casp3↑, 41,   cl‑Casp3↑, 7,   proCasp3↓, 2,   proCasp3↑, 1,   Casp7↑, 5,   Casp8↑, 6,   Casp9↑, 20,   cl‑Casp9↑, 1,   cFLIP↓, 2,   Cyt‑c↓, 1,   Cyt‑c↑, 25,   Cyt‑c↝, 2,   Diablo↑, 1,   DR5↑, 6,   Endon↑, 1,   FADD↑, 2,   Fas↑, 5,   FasL↑, 1,   Ferroptosis↑, 7,   GSDMC↑, 1,   GSDME↑, 1,   GSDME-N↑, 1,   IAP1↓, 1,   iNOS↓, 2,   iNOS↑, 1,   Mcl-1↓, 8,   MDM2↓, 4,   MEG3↑, 1,   MLKL↑, 1,   MOMP↑, 2,   Necroptosis↑, 3,   necrosis↑, 1,   NOXA↑, 2,   p38↓, 2,   p38↑, 6,   PUMA↑, 3,   Pyro↑, 5,   RIP3↑, 1,   survivin↓, 11,   TRAIL↑, 1,   TumCD↑, 6,   TumCD∅, 1,   XIAP↓, 4,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 58,   Akt↑, 3,   p‑Akt↓, 15,   p‑Akt↑, 1,   AKT1↓, 4,   CaMKII ↓, 1,   cMET↓, 2,   p‑cMET↑, 1,   EGFR↓, 15,   ERK↓, 15,   ERK↑, 3,   ERK↝, 1,   p‑ERK↓, 1,   FGFR1↓, 1,   HER2/EBBR2↓, 6,   p‑HER2/EBBR2↓, 1,   IGF-1R↓, 4,   p‑IGF-1R↓, 1,   IKKα↓, 1,   IκB↓, 1,   IκB↑, 1,   JAK↓, 2,   JAK1↓, 1,   JAK2↓, 5,   JNK↓, 2,   JNK↑, 7,   MAP2K1/MEK1↓, 1,   MAPK↓, 7,   MAPK↑, 3,   MAPK↝, 1,   MEK↓, 2,   mTOR?, 1,   mTOR↓, 47,   p‑mTOR↓, 5,   P70S6K↓, 2,   p‑P70S6K↓, 2,   P90RSK↓, 1,   PAK↓, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 38,   PI3K↑, 1,   p‑PI3K↓, 1,   PI3K/Akt↓, 1,   PI3k/Akt/mTOR↓, 1,   PKA↓, 5,   PKCδ↓, 4,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 17,   Raf↓, 2,   RAS↓, 2,   RET↓, 1,   RIP1↓, 1,   RIP1↑, 1,   p‑RIP1↑, 1,   p‑S6K↓, 2,   SHP1↑, 1,   Sp1/3/4↓, 8,   Sp1/3/4↑, 1,   p‑Src↓, 1,   STAT↓, 1,   STAT3↓, 21,   STAT3↑, 1,   p‑STAT3↓, 9,   STAT5↓, 1,   p‑STAT5↓, 1,   STAT6↓, 2,   STK11/LKB1↑, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 5,   ATF4↝, 1,   cJun↓, 1,   cMyc↓, 33,   DNMT1↓, 1,   DNMTs↓, 1,   FOXO↑, 1,   FOXO3↑, 1,   p‑FOXO3↓, 2,   ac‑H4↓, 1,   HATs↓, 1,   HDAC↓, 8,   HDAC8↓, 1,   miR-122-5p↑, 1,   miR-126↑, 1,   miR-140↑, 1,   miR-145↑, 1,   miR-155↓, 1,   miR-195↑, 1,   miR-199↑, 1,   miR-200c↑, 1,   miR-206↑, 1,   miR-21↓, 2,   miR-21↑, 1,   miR-221↑, 1,   miR-222↑, 1,   miR-29b↓, 1,   miR-30a-5p↑, 1,   miR-326-5p↑, 1,   miR-339-5p↑, 1,   miR-339-5p↝, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-34b-5p↑, 1,   miR-375↑, 1,   Myc↓, 3,   n-MYC↓, 1,   OCT4↓, 6,   other↓, 1,   other↑, 3,   other↝, 10,   SOX2↓, 6,   SOX4↓, 1,   SOX4↑, 1,   TBX15↑, 1,   TET3↑, 1,   tumCV↓, 25,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 1,   CHOP/DDIT3↑, 13,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 2,   eIF2α↑, 5,   p‑eIF2α↑, 3,   ER Stress↑, 23,   GRP78/BiP↓, 1,   GRP78/BiP↑, 6,   HSP70/HSPA5↓, 2,   HSP70/HSPA5↑, 1,   HSP90↓, 4,   IRE1↑, 2,   PERK↑, 7,   UPR↑, 4,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 2,   ATG5↑, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 3,   LAMP2↑, 2,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3B↓, 1,   LC3B-II↑, 2,   LC3II↑, 4,   LC3s↓, 1,   p62↓, 4,   p62↑, 4,   RUBCN↓, 1,   TumAuto↓, 1,   TumAuto↑, 27,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

BRCA1↓, 1,   DNAdam↓, 3,   DNAdam↑, 16,   DNAdam⇅, 1,   mt-DNAdam↑, 1,   DNArepair↓, 2,   DNArepair↑, 1,   hTERT/TERT↓, 4,   P53↑, 26,   p‑P53↑, 1,   PARP↓, 2,   PARP↑, 4,   cl‑PARP↓, 1,   cl‑PARP↑, 15,   cl‑PARP↝, 1,   proPARP↓, 2,   PCNA↓, 7,   SIRT6↑, 1,   Telomerase↓, 5,   TOP1↓, 2,   TOP2↓, 2,   TP53↓, 1,   TRF2↓, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 4,   CDK2↓, 8,   CDK4↓, 9,   CDK6↓, 6,   CDK8↓, 1,   CHK1↓, 1,   Chk2↓, 1,   Cyc↓, 1,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 3,   CycB/CCNB1↑, 2,   cycD1/CCND1↓, 17,   cycD1/CCND1↑, 2,   cycE/CCNE↓, 3,   cycE/CCNE↑, 1,   E2Fs↑, 1,   Ki-67↓, 12,   P21↓, 1,   P21↑, 16,   p27/CDKN1B↑, 6,   pRB↑, 1,   p‑pRB↓, 1,   RB1↓, 1,   p‑RB1↓, 3,   TumCCA↓, 3,   TumCCA↑, 53,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   p‑4E-BP1↓, 1,   ALDH↓, 2,   ALDH1A1↓, 2,   BMI1↓, 1,   CD133↓, 1,   CD24↓, 1,   CEBPB?, 1,   cFos↓, 1,   CSCs↓, 17,   Diff↓, 1,   Gli1↓, 4,   GTPBP4↓, 1,   HH↓, 3,   IGF-1↓, 4,   IGF-1↝, 1,   IGFBP1↑, 1,   Ki-67↓, 12,   Let-7↑, 3,   mTORC1↓, 3,   p‑mTORC1↓, 1,   Nanog↓, 6,   Nestin↓, 1,   NOTCH↓, 5,   NOTCH1↓, 2,   NOTCH1↑, 2,   PTCH1↓, 1,   Shh↓, 3,   Smo↓, 2,   STAT1↓, 1,   TumCG↓, 57,   TumCG↑, 3,   TumCP↓, 87,   TumCP↑, 1,   Wnt↓, 11,   Wnt/(β-catenin)↓, 4,   Zn2+↑, 1,  

Migration(tgid=13) ⓘ

AntiAg?, 1,   AP-1↓, 4,   APC↑, 1,   ATPase↓, 1,   AXL↓, 1,   Ca+2?, 1,   Ca+2↓, 3,   Ca+2↑, 12,   Ca+2↝, 2,   i-Ca+2↓, 1,   i-Ca+2↑, 1,   CAFs/TAFs↓, 1,   Cav1↑, 2,   E-cadherin↓, 1,   E-cadherin↑, 14,   EMT↓, 26,   EMT↝, 1,   F-actin↑, 1,   FAK↓, 2,   p‑FAK↓, 2,   Furin↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB6↓, 1,   KRAS↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP-10↓, 1,   MMP13↓, 1,   MMP2↓, 19,   MMP3↓, 3,   MMP7↓, 1,   MMP9↓, 24,   MMP9↑, 1,   MMP9:TIMP1↓, 1,   MMPs↓, 8,   N-cadherin↓, 11,   Rho↓, 1,   ROCK1↓, 1,   Slug↓, 6,   SMAD3↓, 1,   Snail?, 1,   Snail↓, 7,   SPARC↑, 2,   T-cadherin↓, 1,   talin↓, 1,   TET1↑, 3,   TGF-β↓, 4,   TIMP1↓, 2,   TIMP2↓, 2,   TRIB3↑, 1,   TSC1↑, 1,   TumCA↓, 2,   TumCA↑, 1,   TumCI↓, 38,   TumCMig↓, 33,   TumCMig↑, 1,   TumMeta↓, 31,   TumMeta↑, 1,   Twist↓, 7,   uPA↓, 5,   uPAR↓, 1,   Vim↓, 8,   Zeb1↓, 2,   ZEB2↓, 1,   α-SMA↓, 2,   α-SMA↑, 1,   β-catenin/ZEB1↓, 15,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 33,   angioG↑, 1,   Endoglin↑, 1,   eNOS↑, 1,   HIF-1↓, 1,   Hif1a↓, 77,   Hif1a↑, 2,   Hypoxia↓, 1,   Hypoxia↑, 1,   NO↓, 1,   NO↑, 1,   VCAM-1↓, 1,   VEGF↓, 31,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 4,   VM↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   CX43/GJA1↓, 1,   EPR↓, 1,   EPR↑, 1,   GLUT1↓, 46,   GLUT1↑, 3,   GLUT2↓, 5,   GLUT3↓, 4,   GLUT3↑, 1,   GLUT4↓, 3,   MMP↓, 38,   MMP↑, 2,   MMP↝, 1,   MPT↑, 5,   NHE1↓, 4,   SMCT1∅, 1,   TRPV1↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD25+↑, 1,   CD4+↑, 2,   CD44↓, 5,   CD8+↑, 2,   COX1↓, 1,   COX2/PTGS2↓, 15,   COX2/PTGS2↑, 1,   CXCR4↓, 3,   DR4↑, 2,   FOXP3↑, 2,   HLA-I/II↑, 1,   HMGB1↓, 1,   ICAM-1↓, 3,   IFN-γ↑, 1,   IL1↓, 1,   IL1↑, 1,   IL10↓, 3,   IL10↑, 1,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 5,   IL1β↑, 1,   IL2↑, 1,   IL4↓, 2,   IL6↓, 14,   IL8↓, 2,   Imm↑, 4,   Imm↝, 2,   Inflam↓, 12,   pol-M1↑, 1,   M2 MC↓, 3,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 2,   MCT1↓, 3,   NF-kB↓, 35,   NF-kB↑, 3,   p‑NF-kB↓, 2,   NK cell↑, 4,   NLRP3↓, 3,   p65↓, 3,   PD-L1↓, 7,   PGE2↓, 3,   PSA↓, 2,   RAGE↑, 1,   T-Cell↑, 2,   T-Cell↝, 1,   TLR4↓, 3,   TNF-α↓, 8,   TNF-α↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,   e-pH↑, 1,   i-pH↓, 3,   TAMS↝, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↑, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3,   ER-α36↓, 1,   Estro↝, 1,   PPARγ↓, 2,   PPARγ↑, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 2,   BioAv↓, 19,   BioAv↑, 20,   BioAv↝, 5,   BioEnh?, 1,   BioEnh↑, 2,   ChemoSen↓, 2,   ChemoSen↑, 65,   CompStab↓, 1,   CompStab↑, 2,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   Dose?, 5,   Dose↓, 3,   Dose↑, 5,   Dose↝, 21,   Dose∅, 6,   eff↓, 29,   eff↑, 49,   eff↝, 9,   GSTP1/GSTπ↝, 1,   GSTZ1↓, 1,   GSTZ1↝, 1,   Half-Life↓, 5,   Half-Life↝, 4,   MDR1↓, 2,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 5,   P450↓, 1,   RadioS↑, 29,   selectivity↑, 39,   Synergy↑, 64,   Synergy↝, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AR↓, 3,   AST↓, 2,   BG↓, 2,   BloodF↑, 1,   BRCA1↓, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 15,   Ferritin↓, 2,   HER2/EBBR2↓, 6,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 4,   IL6↓, 14,   KRAS↓, 1,   LDH↓, 20,   LDH↑, 2,   LDH∅, 1,   e-LDH↑, 2,   Myc↓, 3,   PD-L1↓, 7,   PSA↓, 2,   RAGE↑, 1,   TG/TAG↓, 1,   TP53↓, 1,   TRIB3↑, 1,   XIST↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 12,   antiNeop↑, 1,   AntiTum↑, 9,   cachexia↓, 1,   cardioP↑, 2,   CardioT↓, 1,   chemoP↓, 1,   chemoP↑, 2,   chemoPv↑, 1,   ChemoSideEff↓, 3,   fatigue↓, 2,   hepatoP↓, 1,   Mucositis↓, 1,   neuroP↑, 5,   NP/CIPN↑, 1,   OS↑, 9,   OS∅, 2,   Pain↓, 1,   PFS∅, 1,   QoL↑, 2,   radioP↑, 3,   Remission↑, 2,   Risk↓, 5,   Sleep↑, 1,   Strength↑, 1,   toxicity↓, 16,   toxicity↑, 4,   toxicity↝, 7,   toxicity∅, 1,   TumVol↓, 14,   TumW↓, 12,   Weight∅, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 2,   GutMicro↑, 5,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 783

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 22,   mt-antiOx↑, 1,   ARE↑, 2,   Catalase↑, 8,   GPx↑, 10,   GPx1↑, 3,   GPx4↑, 3,   GSH↑, 8,   GSR↑, 2,   GSTs↑, 1,   HDL↑, 2,   HNE↓, 1,   HO-1↓, 1,   HO-1↑, 6,   i-Iron↓, 1,   Keap1↓, 1,   lipid-P↓, 5,   lipidDe↓, 1,   MDA↓, 6,   NADPH/NADP+↑, 1,   NOX4↓, 1,   NQO1↑, 3,   NRF2↑, 14,   Prx↑, 1,   ROS↓, 32,   ROS↑, 2,   mt-ROS↓, 2,   mt-ROS↑, 1,   SOD↑, 11,   SOD1↑, 3,   SOD2↑, 2,   TAC↑, 1,   Trx↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 2,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   DRP1/DNM1L↓, 1,   EGF↓, 1,   ETC↑, 1,   Insulin↓, 1,   MFN1↑, 1,   MFN2↑, 1,   mitResp↓, 1,   OCR↓, 1,   OCR↑, 1,   OPA1↑, 1,   OXPHOS↓, 3,   OXPHOS↑, 5,   PGC-1α↑, 5,   UCP1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 1,   p‑ACC↑, 1,   mt-ACC⇅, 1,   ACLY∅, 1,   ALAT↓, 3,   AMPK↓, 1,   AMPK↑, 3,   p‑AMPK↑, 1,   ATP↓, 2,   ATP↑, 6,   BMAL1↑, 1,   ECAR↓, 4,   ECAR↑, 1,   ECAR∅, 1,   FAO↑, 3,   FASN↓, 1,   FFA/NEFA↓, 1,   glucoNG↓, 1,   glucose↓, 3,   glucose↝, 3,   GlucoseCon↓, 3,   GlucoseCon↑, 4,   Glycolysis↓, 9,   Glycolysis↑, 11,   Glycolysis↝, 4,   H2S↑, 1,   HK1↑, 1,   HK2↓, 5,   HK2↑, 6,   HMG-CoA↓, 1,   lactateProd↓, 5,   LDHA↓, 2,   LDHA↑, 3,   LDHB↑, 1,   LDL↓, 2,   lipidLev↓, 1,   NAD↓, 1,   NAD↑, 1,   NADPH↓, 2,   NADPH↑, 1,   NH3↑, 1,   PDKs↓, 1,   PDKs↑, 1,   PFK↓, 2,   PFK↑, 1,   PFK1↓, 1,   PFK2↓, 1,   PFKL↑, 2,   PFKM↑, 2,   PFKP↓, 1,   PFKP↑, 1,   PKM1↑, 1,   PKM2↓, 3,   PKM2↑, 7,   PPP↓, 2,   SIRT1↑, 3,   SIRT2↑, 1,   SREBP1/SREBF1↓, 1,   TCA↑, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 4,   BAX↓, 1,   Bcl-2↓, 1,   Casp↓, 1,   Casp3↓, 3,   Casp9↓, 3,   Cyt‑c↓, 1,   Fas↓, 1,   Ferroptosis↓, 1,   iNOS↓, 2,   Pyro↓, 1,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   ERK↓, 1,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   Hippo↑, 1,   IGFR↓, 1,   JNK↓, 1,   MAPK↓, 4,   mTOR↓, 2,   PI3K↓, 2,   PKCδ↑, 1,   RAS↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↓, 1,   ATF4↑, 1,   HDAC↓, 1,   other?, 1,   other↝, 4,   tumCV↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   P53↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

IGF-1↓, 3,   IGFBP3↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   Ca+2↓, 3,   Cartilage↑, 1,   EMT↑, 1,   TumCMig↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   E-sel↓, 1,   HIF-1↓, 1,   Hif1a↓, 4,   Hif1a↑, 2,   Hif1a∅, 1,   NO↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   GLUT1↑, 2,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 4,   MMP↑, 2,   MMP↝, 1,   MUC5AC↓, 1,   TRPC1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   COX2/PTGS2↓, 5,   CXCL1↓, 1,   CXCL12↑, 1,   IFN-γ↓, 1,   IL10↓, 2,   IL17↓, 2,   IL1β↓, 3,   IL2↓, 1,   IL6↓, 5,   IL8↓, 2,   Imm↓, 1,   Inflam?, 1,   Inflam↓, 26,   NF-kB↓, 9,   NLRP3↓, 1,   NLRP3↑, 1,   PAR-2↓, 1,   PGE2↓, 1,   TLR4↓, 3,   TNF-α↓, 8,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 1,   BDNF↓, 1,   GABA↝, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 4,   tau↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

FGF21↑, 1,   PPARα↑, 2,   PPARα↝, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 9,   BioAv↑, 8,   BioAv↝, 5,   BioEnh↑, 1,   Dose↝, 6,   eff↝, 1,   Half-Life↓, 2,   Half-Life↝, 1,   Half-Life∅, 1,   selectivity↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   AST↓, 3,   BP↓, 1,   IL6↓, 5,   IRes↓, 1,   LDH↓, 1,   TC↓, 1,   TG/TAG↓, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 4,   antiAll↑, 3,   AntiArt↑, 1,   AntiCan↓, 1,   AntiCan↑, 1,   AntiDiabetic↑, 5,   antiPs↑, 1,   cardioP↓, 1,   cardioP↑, 7,   cognitive↑, 7,   diuretic↑, 1,   hepatoP↑, 11,   memory↑, 5,   motorD↑, 1,   neuroP↓, 1,   neuroP↑, 17,   Obesity↓, 1,   OS↑, 1,   RenoP↑, 4,   Risk↓, 1,   Stroke↓, 3,   toxicity↓, 11,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 4,  

Infection & Microbiome(tgid=24) ⓘ

AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 3,   GutMicro↑, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 258

Scientific Paper Hit Count for: Glycolysis, Glycolysis
20 Shikonin
14 3-bromopyruvate
12 Citric Acid
12 Dichloroacetate
12 Sulforaphane (mainly Broccoli)
11 Baicalein
10 Kaempferol
10 Melatonin
9 Resveratrol
8 Metformin
8 EGCG (Epigallocatechin Gallate)
8 Quercetin
7 Artemisinin
7 Berberine
7 Propolis -bee glue
7 Magnetic Fields
6 Curcumin
6 Vitamin C (Ascorbic Acid)
5 Alpha-Lipoic-Acid
5 Apigenin (mainly Parsley)
5 Ashwagandha(Withaferin A)
5 Betulinic acid
5 Diclofenac
4 Chrysin
4 Chemotherapy
4 Emodin
4 Galloflavin
4 Honokiol
4 Methylene blue
4 Ursolic acid
4 Vitamin D3
3 2-DeoxyGlucose
3 5-fluorouracil
3 Capsaicin
3 Chlorogenic acid
3 Cinnamon
3 diet FMD Fasting Mimicking Diet
3 Isoliquiritigenin
3 Piperlongumine
3 Silymarin (Milk Thistle) silibinin
2 Radiotherapy/Radiation
2 DTS(dibenzyl trisulphide) from Anamu
2 Brucea javanica
2 salinomycin
2 Ellagic acid
2 Fenbendazole
2 Licochalcone A
2 Licorice
2 Luteolin
2 Matrine
2 Cisplatin
2 Methyl Jasmonate
2 methylseleninic acid
2 Methylglyoxal
2 Mushroom Chaga, Inonotus obliquus
2 Oroxylin-A
2 Phenylbutyrate
2 Rosmarinic acid
2 Thymoquinone
2 Wogonin
1 Sorafenib (brand name Nexavar)
1 5-Aminolevulinic acid
1 Auranofin
1 Astragalus
1 Silver-NanoParticles
1 Allicin (mainly Garlic)
1 tamoxifen
1 Baicalin
1 Benzyl isothiocyanate
1 Boron
1 Boswellia (frankincense)
1 brusatol
1 Caffeic acid
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Carnosine
1 Celecoxib
1 Celastrol
1 Cichoric acid / Chicoric acid
1 Calorie Restriction Mimetics
1 HydroxyCitric Acid
1 nicotinamide adenine dinucleotide
1 Spermidine
1 Dichloroacetophenone(2,2-)
1 Bortezomib
1 Deguelin
1 diet Methionine-Restricted Diet
1 Diindolylmethane
1 Ormeloxifene (Centchroman)
1 Dandelion Root
1 Piperine
1 Eugenol
1 Ferulic acid
1 flavonoids
1 Ginkgolide B
1 Ginseng
1 Glabrescione B
1 Gossypol/AT-101
1 Hydrogen Gas
1 hydrogen sulfide
1 Hydroxycinnamic-acid
1 Inositol
1 Isorhamnetin
1 isoquercitrin
1 Isothiocyanates
1 itraconazole
1 Ivermectin
1 lambertianic acid
1 Lapachol
1 doxorubicin
1 Lycopene
1 Mangiferin
1 Moringa oleifera
1 Niclosamide (Niclocide)
1 Nimbolide
1 Proanthocyanidins
1 Phenethyl isothiocyanate
1 Pterostilbene
1 Rutin
1 Docetaxel
1 VitK3,menadione
1 triptolide
1 Tumor Treating Fields
1 Arsenic trioxide
1 Selenite (Sodium)
1 Vitamin K2
1 β‐Elemene
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:129  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page